Verona Pharma plc (NASDAQ:VRNA) Shares Acquired by Affinity Asset Advisors LLC

Affinity Asset Advisors LLC raised its position in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 8.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 452,821 shares of the company’s stock after purchasing an additional 35,323 shares during the quarter. Verona Pharma makes up approximately […]

Related Keywords

David Zaccardelli ,Kathleena Rickard ,Verona Pharma ,Securities Exchange Commission ,Tower Research Capital ,Tucker Asset Management ,Goldman Sachs Group Inc ,Nasdaq ,Canaccord Genuity Group ,Affinity Asset Advisors ,Sg Americas Securities ,Free Report ,Asset Advisors ,Asset Management ,Sachs Group ,Research Capital ,Exchange Commission ,Genuity Group ,Pharma Stock Down ,Get Free Report ,Visit Holdingschannel ,Verona Pharma Daily ,Nasdaq Vrna ,Vrna ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,